Semi-Annual Consolidated Statement Of Cash Flows

Medrx Co.,Ltd. - Filing #7712143

Concept As at
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2017-01-01 to
2017-12-31
As at
2017-12-31
2017-01-01 to
2017-12-31
As at
2016-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,265,227,000 JPY
-1,265,806,000 JPY
-880,044,000 JPY
-978,194,000 JPY
Depreciation
39,911,000 JPY
59,171,000 JPY
Interest and dividend income
-659,000 JPY
-401,000 JPY
Share of loss (profit) of entities accounted for using equity method
JPY
758,000 JPY
Decrease (increase) in inventories
-7,878,000 JPY
-10,827,000 JPY
Increase (decrease) in trade payables
58,000 JPY
-108,000 JPY
Other, net
-210,000 JPY
-5,038,000 JPY
Subtotal
-1,275,340,000 JPY
-891,557,000 JPY
Interest and dividends received
659,000 JPY
401,000 JPY
Income taxes paid
-4,176,000 JPY
-4,720,000 JPY
Net cash provided by (used in) operating activities
-1,260,847,000 JPY
-854,320,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-42,460,000 JPY
-50,486,000 JPY
Net cash provided by (used in) investing activities
568,539,000 JPY
-661,486,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
1,362,170,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
215,000 JPY
2,664,000 JPY
Net increase (decrease) in cash and cash equivalents
670,076,000 JPY
-1,513,142,000 JPY
Cash and cash equivalents
1,796,871,000 JPY
1,126,794,000 JPY
2,639,936,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.